New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
10:25 EDTSGYP, SGYPSummer Street's chief scientific officer holds analyst/industry conference call
Chief Scientific Officer Classen discusses Synergy Pharmaceuticals' (SGYP) Plecanatide for Irritable Bowel Disease with constipation on an Analyst/Industry conference call to be held on April 17 at 11 am.
News For SGYP From The Last 14 Days
Check below for free stories on SGYP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
06:02 EDTSGYPSynergy Pharmaceuticals reaches halfway mark for Phase 3 plecanatide trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use